Antibody Therapeutics for Life

Press Release

No Title Written by Written date Inquire
16   PharmAbcine to participate at BIO-Europe 2020   PharmAbcine   2020-10-29   16  
15   PharmAbcine expands partnership with Samsung Biologics for PMC-403   PharmAbcine   2020-09-22   3,946  
14   PharmAbcine Unveils Olinvacimab’s Positive Results from Phase Ib Combination Studies at KSMO 2020   PharmAbcine   2020-09-15   168  
13   PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line   PharmAbcine   2020-09-03   188  
12   PharmAbcine is presenting at the KSMO 2020   PharmAbcine   2020-09-03   183  
11   PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS PharmAbcineLogo (PRNewsfoto/PharmAbcine)   PharmAbcine   2020-08-20   3,136  
10   PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC   PharmAbcine   2020-08-20   238  
9   PharmAbcine to Present Preclinical Data of Blood Vessel Stabilizing PMC-402 at 2020 AACR Meeting   PharmAbcine   2020-05-20   15,087  
8   Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment   PharmAbcine   2020-04-07   16,323  
7   PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting   PharmAbcine   2020-04-06   20,254